Monopar Therapeutics
MNPR
#7537
Rank
โ‚น43.32 B
Marketcap
โ‚น6,394
Share price
-1.84%
Change (1 day)
-22.06%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): -โ‚น174.50

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น176.98. In 2025 the company made an earnings per share (EPS) of -โ‚น171.42 an increase over its 2024 EPS that were of -โ‚น380.83.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น174.501.79%
2025-โ‚น171.42-54.99%
2024-โ‚น380.8335.2%
2023-โ‚น281.69-26.75%
2022-โ‚น384.5413.7%
2021-โ‚น338.2125.86%
2020-โ‚น268.7128.89%
2019-โ‚น208.4945.28%
2018-โ‚น143.51-80.5%
2017-โ‚น736.001296.33%
2016-โ‚น52.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น125.09-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA